JTG-37077-30652 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2020-12-30
Registered in v-safe
2020-12-30
Dose 1 — Pfizer-BioNTech
2020-12-31
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain · Fatigue or tiredness

Adult check-in
2021-01-01
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain · Fatigue or tiredness

Adult check-in
2021-01-02
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Fatigue or tiredness

Adult check-in
2021-01-03
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-01-04
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Headache

Adult check-in
2021-01-05
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-01-06
Health check-in — day 7, dose 1
Feeling: Good · None

Adult check-in
2021-01-13
Health check-in — day 14, dose 1
Feeling: Good

Adult check-in
2021-01-17
Dose 2 — Pfizer-BioNTech
2021-01-27
Health check-in — day 7, dose 2
Feeling: Good · Site: Pain · None

Adult check-in
2021-01-31
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-02-07
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2021-02-14
Health check-in — day 28, dose 2
Feeling: Good

Adult check-in
2021-02-21
Survey response — day 35, dose 2
MedDRA: Hospitalisation, Pre-eclampsia — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit, Hospitalization

Free text: Postpartum preeclampsia- hospitalized for 2 days, day 5 postpartum.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-21
Report sent to call center — day 35, dose 2
Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

1 call case(s)
2021-02-28
Survey response — day 42, dose 2
MedDRA: Eclampsia, Postpartum state, Pre-eclampsia — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Emergency room or emergency department visit, Hospitalization

Free text: Postpartum preeclampsia

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-28
Report sent to call center — day 42, dose 2
Get care from a doctor or other healthcare professional

1 call case(s)
2021-03-16
Call 1 — Left Voicemail
2021-04-19
Health check-in — 3 months, dose 2
Feeling: Good

Adult check-in
2021-05-03
Call 1 — Could Not Reach Participant
2021-05-06
Call 2 — Could Not Reach Participant
2021-07-20
Health check-in — 6 months, dose 2
Feeling: Good

Adult check-in
2022-01-17
Health check-in — 12 months, dose 2
Feeling: Good

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2020-12-30	Pfizer-BioNTech
2	2021-01-17	Pfizer-BioNTech

Call center

2 call center cases

2 unsuccessful

See the call center timeline

Free text

Release 4 — day 35, dose 2

2021-02-21

Symptoms: Postpartum preeclampsia- hospitalized for 2 days, day 5 postpartum.

Release 4 — day 42, dose 2

2021-02-28

Symptoms: Postpartum preeclampsia

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Eclampsia	○	✓	○
SD	Hospitalisation	✓	✓	✓
SD	Postpartum state	✓	·	✓
SD	Pre-eclampsia	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release